SQUAWK/NEWS
Account
Account
Menu
Live News EARNINGS FLASH L impact

Vivos Therapeutics schedules Q2 2026 results release

Vivos Therapeutics (VVOS) schedules the release of its second quarter 2026 financial results and a conference call, per the company’s announced timing.

VVOS

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.